Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
UP International Grants Genomma Lab The Exclusive License For Novamil® / Novalac® Infant Nutrition Products In Mexico | ||
By: PR Newswire Association LLC. - 13 Sep 2019 | Back to overview list |
|
MEXICO CITY, Sept. 12, 2019 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence is pleased to announce that it has signed an exclusive license agreement with UP International, S. A. ("UPI") to market the full range of infant nutrition products under the Novamil® and Novalac® brands in Mexico. UPI has developed nutritional supplements for pregnant and lactating mothers as well as unique infant formulas to manage and alleviate digestive disorders frequently occurring the first years of life including gastrointestinal discomfort, allergies, reflux and constipation, among others. The efficacy of Novamil® / Novalac® specialty products has been demonstrated in over 40 clinical trials and studies, mostly in Europe, involving over 48.000 infants worldwide. These infant nutrition formulas are endorsed by leading pharmaceutical companies in five continents, and now by Genomma Lab in Mexico. The UPI-Genomma exclusive licensing agreement will leverage on Genomma's Growth and Innovation Strategy, as well as the Company strengths and capabilities on Marketing, Advertising, its best in class go-to-market and supply chain models. Genomma will also develop and integrate a team of highly trained medical reps to inform medical professionals, pediatricians and gastro-pediatricians. UPI Pharmaceuticals and Genomma Lab strongly support breastfeeding as the best nutrition for babies. About UP International UPI's goal is to continue developing ever-improving solutions to promote and support breastfeeding as well as adequate nutrition for babies who cannot be breastfed. About Genomma Lab Internacional Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker "LABB" (Bloomberg: LABB:MM). Note on Forward-Looking Statements
View original content:http://www.prnewswire.com/news-releases/up-international-grants-genomma-lab-the-exclusive-license-for-novamil--novalac-infant-nutrition-products-in-mexico-300917571.html SOURCE Genomma Lab Internacional, S.A.B. de C.V. |
||
|
||
Copyright 2019 PR Newswire Association LLC. | Back to overview list |